Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report

被引：0
|
作者：
Mehmood, Faisal [1 ]
Touseef, Mumtaz [2 ]
Ashraf, Amna [2 ]
Rai, Izza Ali [3 ]
机构：
[1] Combined Mil Hosp, Dept Radiol, Lahore, Pakistan
[2] Combined Mil Hosp, Dept Med, Lahore, Pakistan
[3] Combined Mil Hosp, Dept Vasc Surg, Lahore, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2024年 / 74卷 / 12期
关键词：
Hereditary breast ovarian cancer; Breast cancer; Ovarian cancer; HBOC; BRCA; PALB2; Chemotherapy; Carboplatin; Paclitaxel; PREVALENCE; MUTATIONS;
D O I：
10.47391/JPMA.20059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The co-occurrence of primary breast cancer and primary ovarian cancer is an exceptional hereditary phenomenon and results from inherent mutations in critical genes like a unique case of hereditary breast-ovarian cancer syndrome (HBOC) reported in Combined Military Hospital, Lahore, Pakistan. It was marked by pathogenic variants in RAD51D, PALB2, CHEK1, and TP53 genes. Remarkably, the patient exhibited an outstanding response to the chemotherapy agents, Carboplatin and Paclitaxel. This dynamic treatment not only led to nearly complete remission of high-grade ovarian serous cancer but also triggered regression in grade-2 invasive ductal breast cancer after just a few rounds of chemotherapy. Consequently, what started as palliative care evolved into a curative triumph.
引用
收藏
页码：2184 / 2187
页数：4
相关论文
共 50 条
  • [41] An Overview of Hereditary Breast and Ovarian Cancer Syndrome
    Smith, Edith Caroline
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2012, 57 (06) : 577 - 584
  • [42] Hereditary breast and ovarian cancer syndrome: A misnomer?
    Weiss, Jessica M.
    Ahsan, Muhammad Danyal
    Webster, Emily M.
    Levi, Sarah R.
    Qazi, Murtaza
    Harvey, Benedict
    Cantillo, Evelyn
    Holcomb, Kevin
    Chapman-Davis, Eloise
    Sharaf, Ravi N.
    Frey, Melissa Kristen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis - case report
    Yokoyama, Y.
    Futagami, M.
    Higuchi, T.
    Mizunuma, H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (04) : 437 - 439
  • [44] Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families
    C.F. Singer
    M.K. Tea
    G. Pristauz
    M. Hubalek
    C. Rappaport
    C.C. Riedl
    T.H. Helbich
    Wiener klinische Wochenschrift, 2015, 127 : 981 - 986
  • [45] Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
    Pons, Daniel G.
    Sastre-Serra, Jorge
    Nadal-Serrano, Mercedes
    Oliver, Aina
    Garcia-Bonafe, Magdalena
    Bover, Isabel
    Roca, Pilar
    Oliver, Jordi
    ANTICANCER RESEARCH, 2012, 32 (11) : 4723 - 4728
  • [46] Carboplatin/paclitaxel/pembrolizumabLack of efficacy and antibody syndrome: case report
    Reactions Weekly, 2025, 2051 (1) : 82 - 82
  • [47] Gallbladder Cancer Showing a Great Response to Paclitaxel Plus Carboplatin Chemotherapy: A Case Report
    Inoue, Yoshihiro
    Ota, Masato
    Fujii, Kensuke
    Matsuda, Junna
    Kawaguchi, Nao
    Imai, Yoshiro
    Shimizu, Tetsunosuke
    Asakuma, Mitsuhiro
    Takeshita, Atsushi
    Hirokawa, Fumitoshi
    Hayashi, Michihiro
    Uchiyama, Kazuhisa
    INTERNATIONAL SURGERY, 2018, 103 (1-2) : 66 - 71
  • [48] Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families
    Singer, C. F.
    Tea, M. K.
    Pristauz, G.
    Hubalek, M.
    Rappaport, C.
    Riedl, C. C.
    Helbich, T. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (23-24) : 981 - 986
  • [49] Enhancing cancer genomics practice in public health departments to identify women at high risk for hereditary breast and ovarian cancer syndrome (HBOC)
    Martin, Monique L.
    Kerber, Alice
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [50] Genetic and clinical characterization of multigene hereditary breast and ovarian cancer (HBOC) panels in Malaga (Spain).
    Pajares, Bella
    Campos, Marcos Iglesias
    Diaz, Tamara
    Peralta, Rafael Jesus
    Alba, Emilio
    Marquez, Antonia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345